GLP1R and metabolic dysfunction-associated steatotic liver disease: Relevant probiotic studies have shown that VSL#3 stimulates GLP-1 release, reducing food intake, improving glucose tolerance, and alleviating nonalcoholic fatty liver disease in children via enhanced GLP-1 [51].